全文获取类型
收费全文 | 9894022篇 |
免费 | 633989篇 |
国内免费 | 142558篇 |
专业分类
耳鼻咽喉 | 129711篇 |
儿科学 | 280592篇 |
妇产科学 | 230678篇 |
基础医学 | 1224759篇 |
口腔科学 | 261423篇 |
临床医学 | 982887篇 |
内科学 | 1645373篇 |
皮肤病学 | 202405篇 |
神经病学 | 719171篇 |
特种医学 | 373539篇 |
外国民族医学 | 1661篇 |
外科学 | 1316779篇 |
综合类 | 696189篇 |
一般理论 | 3726篇 |
预防医学 | 781837篇 |
眼科学 | 226524篇 |
药学 | 854357篇 |
2260篇 | |
中国医学 | 206418篇 |
肿瘤学 | 530280篇 |
出版年
2022年 | 79019篇 |
2021年 | 160097篇 |
2020年 | 136756篇 |
2019年 | 133170篇 |
2018年 | 163905篇 |
2017年 | 154872篇 |
2016年 | 139862篇 |
2015年 | 179865篇 |
2014年 | 273303篇 |
2013年 | 365151篇 |
2012年 | 518499篇 |
2011年 | 563073篇 |
2010年 | 382097篇 |
2009年 | 343776篇 |
2008年 | 480884篇 |
2007年 | 501711篇 |
2006年 | 479064篇 |
2005年 | 441093篇 |
2004年 | 387983篇 |
2003年 | 359497篇 |
2002年 | 330974篇 |
2001年 | 311001篇 |
2000年 | 309211篇 |
1999年 | 263092篇 |
1998年 | 103092篇 |
1997年 | 90131篇 |
1996年 | 84171篇 |
1995年 | 83077篇 |
1994年 | 75404篇 |
1993年 | 64373篇 |
1992年 | 182429篇 |
1991年 | 176788篇 |
1990年 | 171363篇 |
1989年 | 166352篇 |
1988年 | 153690篇 |
1987年 | 149764篇 |
1986年 | 142646篇 |
1985年 | 136002篇 |
1984年 | 103399篇 |
1983年 | 88623篇 |
1982年 | 56299篇 |
1979年 | 92755篇 |
1978年 | 66511篇 |
1977年 | 57186篇 |
1976年 | 52986篇 |
1975年 | 58083篇 |
1974年 | 67114篇 |
1973年 | 64076篇 |
1972年 | 59298篇 |
1971年 | 54925篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Tyler B. Kratzer MPH Ahmedin Jemal DVM PhD Kimberly D. Miller MPH Sarah Nash PhD Charles Wiggins PhD Diana Redwood PhD Robert Smith PhD Rebecca L. Siegel MPH 《CA: a cancer journal for clinicians》2023,73(2):120-146
American Indian and Alaska Native (AIAN) individuals are diverse culturally and geographically but share a high prevalence of chronic illness, largely because of obstacles to high-quality health care. The authors comprehensively examined cancer incidence and mortality among non-Hispanic AIAN individuals, compared with non-Hispanic White individuals for context, using population-based data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries. Overall cancer rates among AIAN individuals were 2% higher than among White individuals for incidence (2014 through 2018, confined to Purchased/Referred Care Delivery Area counties to reduce racial misclassification) but 18% higher for mortality (2015 through 2019). However, disparities varied widely by cancer type and geographic region. For example, breast and prostate cancer mortality rates are 8% and 31% higher, respectively, in AIAN individuals than in White individuals despite lower incidence and the availability of early detection tests for these cancers. The burden among AIAN individuals is highest for infection-related cancers (liver, stomach, and cervix), for kidney cancer, and for colorectal cancer among indigenous Alaskans (91.3 vs. 35.5 cases per 100,000 for White Alaskans), who have the highest rates in the world. Steep increases for early onset colorectal cancer, from 18.8 cases per 100,000 Native Alaskans aged 20–49 years during 1998 through 2002 to 34.8 cases per 100,000 during 2014 through 2018, exacerbated this disparity. Death rates for infection-related cancers (liver, stomach, and cervix), as well as kidney cancer, were approximately two-fold higher among AIAN individuals compared with White individuals. These findings highlight the need for more effective strategies to reduce the prevalence of chronic oncogenic infections and improve access to high-quality cancer screening and treatment for AIAN individuals. Mitigating the disparate burden will require expanded financial support of tribal health care as well as increased collaboration and engagement with this marginalized population. 相似文献
2.
Kari Hemminki Kristina Sundquist Jan Sundquist Asta Försti Vaclav Liska Akseli Hemminki Xinjun Li 《International journal of cancer. Journal international du cancer》2023,152(6):1107-1114
Many environmental risk factors for hepatobiliary cancers are known but whether they are associated with specific cancer types is unclear. We present here a novel approach of assessing standardized incidence ratios (SIRs) of previously diagnosed comorbidities for hepatocellular carcinoma (HCC), gallbladder cancer (GBC), cholangiocarcinoma (CCA) and ampullary cancer. The 13 comorbidities included alcohol and nonalcohol related liver disease, chronic obstructive pulmonary disease, gallstone disease, viral and other kinds of hepatitis, infection of bile ducts, hepatic and other autoimmune diseases, obesity and diabetes. Patients were identified from the Swedish Inpatient Register from 1987 to 2018, and their cancers were followed from 1997 onwards. SIRs for HCC were 80 to 100 in men and women diagnosed with hepatitis C virus and they were also >10 in patients diagnosed with hepatitis B virus, other kind of hepatitis, hepatic autoimmune disease and nonalcohol related liver disease. Many of these risks, as well as alcohol related liver disease, were either specific to HCC or were shared with intrahepatic CCA. For GBC, CCA and ampullary cancer infection of bile ducts was the main risk factor. Gallstone disease, nonhepatic autoimmune diseases and diabetes were associated with all hepatobiliary cancers. The limitations of the study include inability to cover some rare risk factors and limited follow-up time. Many of the considered comorbidities are characterized by chronic inflammation and/or overt immune disturbance in autoimmune diseases. The results suggest that local chronic inflammation and a related immune disturbance is the carcinogenic trigger for all these cancers. 相似文献
3.
Carlos Casas-Arozamena Cristian Pablo Moiola Ana Vilar Marta Bouso Juan Cueva Silvia Cabrera Victoria Sampayo Efigenia Arias Alicia Abalo Ángel García Ramón Manuel Lago-Lestón Sara Oltra Eva Díaz Juan Ruiz-Bañobre Rafael López-López Gema Moreno-Bueno Antonio Gil-Moreno Eva Colás Miguel Abal Laura Muinelo-Romay 《International journal of cancer. Journal international du cancer》2023,152(10):2206-2217
The analysis of mismatch repair proteins in solid tissue is the standard of care (SoC) for the microsatellite instability (MSI) characterization in endometrial cancer (EC). Uterine aspirates (UAs) or circulating-DNA (cfDNA) samples capture the intratumor heterogeneity and provide a more comprehensive and dynamic molecular diagnosis. Thus, MSI analysis by droplet-digital PCR (ddPCR) in UAs and cfDNA can provide a reliable tool to characterize and follow-up the disease. The UAs, paraffin-embedded tumor tissue (FFPE) and longitudinal plasma samples from a cohort of 90 EC patients were analyzed using ddPCR panel and compared to the SoC. A high concordance (96.67%) was obtained between the analysis of MSI markers in UAs and the SoC. Three discordant cases were validated as unstable by ddPCR on FFPE samples. Besides, a good overall concordance (70.27%) was obtained when comparing the performance of the ddPCR assay on UAs and cfDNA in high-risk tumors. Importantly, our results also evidenced the value of MSI analysis to monitor the disease evolution. MSI evaluation in minimally invasive samples shows great accuracy and sensitivity and provides a valuable tool for the molecular characterization and follow-up of endometrial tumors, opening new opportunities for personalized management of EC. 相似文献
4.
5.
6.
Philip Anglewicz Dana Sarnak Alison Gemmill Stan Becker 《Studies in family planning》2023,54(1):17-38
Although the reproductive calendar is the primary tool for measuring contraceptive dynamics in low-income settings, the reliability of calendar data has seldom been evaluated, primarily due to the lack of longitudinal panel data. In this research, we evaluated the reproductive calendar using data from the Performance Monitoring for Action Project. We used population-based longitudinal data from nine settings in seven countries: Burkina Faso, Nigeria (Kano and Lagos States), Democratic Republic of Congo (Kinshasa and Kongo Central Provinces), Kenya, Uganda, Cote d'Ivoire, and India. To evaluate reliability, we compared the baseline cross-sectional report of contraceptive use (overall and by contraceptive method), nonuse, or pregnancy with the retrospective reproductive calendar entry for the corresponding month, measured at follow-up. We use multivariable regressions to identify characteristics associated with reliability or reporting. Overall, we find that the reliability of the calendar is in the “moderate/substantial” range for nearly all geographies and tests (Kappa statistics between 0.58 and 0.81). Measures of the complexity of the calendar (number of contraceptive use episodes, using the long-acting method at baseline) are associated with reliability. We also find that women who were using contraception without their partners/husband's knowledge (i.e., covertly) were less likely to report reliably in several countries. 相似文献
7.
9.
目的探讨血清总胆红素、尿酸及超敏C反应蛋白水平对冠心病患者诊疗的临床价值。方法选取2019年2—12月本院收治的120例冠心病患者为研究对象,按疾病类型分为稳定型心绞痛(SA)组(n=38)、不稳定性心绞痛(UA)组(n=45)和急性心肌梗死(AMI)组(n=37),另选取同期健康体检者85名作为对照组,检测血清总胆红素、尿酸和超敏C反应蛋白水平,比较3组与对照组各指标水平差异。结果与对照组比较,冠心病组血清总胆红素水平显著降低,而尿酸和超敏C反应蛋白水平显著提升。UA组、SA组和AMI组血清总胆红素、尿酸和超敏C反应蛋白水平比较差异均有统计学意义(P<0.05),且随着患者病情的加重和发展,血清总胆红素水平下降,尿酸和超敏C反应蛋白水平升高。结论血清总胆红素、尿酸及超敏C反应蛋白水平,与UA、SA和AMI的发展密切相关,可作为冠心病进展的风险观察指标。 相似文献
10.